Association of immunoglobulin E levels with glioma risk and survival
Preprint
Abstract
Background Previous epidemiological studies have reported an association of serum immunoglobulin E (IgE) levels with reduced glioma risk, but the association between IgE and glioma prognosis is not well characterized. This study aimed to examine how sex, tumor subtype, and IgE class modulate the association of serum IgE levels with glioma risk and survival. Methods We conducted a case-control study using participants from the University of California, San Francisco Adult Glioma Study (1997-2010). Serum IgE levels for total, respiratory and food allergy were measured in adults diagnosed with glioma (n=1,696) and cancer-free controls (n=1,135) matched based on age, sex, and race/ethnicity. Logistic regression was adjusted for patient demographics to assess the association between IgE levels and glioma risk. Multivariable Cox regression adjusted for patient-specific and tumor-specific factors compared survival between the elevated and normal IgE groups. Results Elevated total IgE was associated with reduced risk of IDH wildtype (OR=0.65, 95% CI: 0.54-0.78) and IDH mutant glioma (OR=0.65, 95% CI: 0.50-0.85). In multivariable Cox regression, elevated respiratory IgE was associated with improved survival for IDH wildtype glioma (HR=0.78, 95% CI: 0.67-0.91). The reduction in mortality risk was more pronounced in females (HR=0.71, 95% CI: 0.53-0.96) than in males (HR=0.80, 95% CI: 0.66-0.97), with improvements in median survival of 6.2 months (P<.001) and 1.6 months (P=0.003), respectively. Conclusion Elevated serum IgE was associated with improved prognosis for IDH wildtype glioma, with a more pronounced protective effect in females. These results suggest a possible sexual dimorphism and antitumor activity of IgE-mediated immune responses.Keywords
All Related Versions
- Published version: JNCI: Journal of the National Cancer Institute, 117 (3), 545.
This publication has 47 references indexed in Scilit:
- Targeting the IL-6/JAK/STAT3 signalling axis in cancerNature Reviews Clinical Oncology, 2018
- Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERTActa Neuropathologica, 2017
- Prevalence of allergic sensitization in the United States: Results from the National Health and Nutrition Examination Survey (NHANES) 2005-2006Journal of Allergy and Clinical Immunology, 2014
- Variants near TERT and TERC influencing telomere length are associated with high-grade glioma riskNature Genetics, 2014
- Antihistamine use and immunoglobulin E levels in glioma risk and prognosisCancer Epidemiology, 2013
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialThe Lancet Oncology, 2009
- IgE, allergy, and risk of glioma: Update from the San Francisco Bay Area Adult Glioma Study in the Temozolomide eraInternational Journal of Cancer, 2009
- History of allergies and autoimmune diseases and risk of brain tumors in adultsInternational Journal of Cancer, 2002
- History of allergies among adults with glioma and controlsInternational Journal of Cancer, 2002
- Precision and accuracy of commercial laboratories' ability to classify positive and/or negative allergen-specific IgE resultsAnnals of Allergy, Asthma & Immunology, 2001